Chemotherapy but Not the Tumor Draining Lymph Nodes Determine the Immunotherapy Response in Secondary Tumors
Summary: Immunotherapies are used as adjuvant therapies for cancers. However, knowledge of how traditional cancer treatments affect immunotherapies is limited. Using mouse models, we demonstrate that tumor-draining lymph nodes (TdLNs) are critical for tumor antigen-specific T cell response. However,...
Main Authors: | Xianda Zhao, Beminet Kassaye, Dechen Wangmo, Emil Lou, Subbaya Subramanian |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-05-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004220302418 |
Similar Items
-
ACKR4 in Tumor Cells Regulates Dendritic Cell Migration to Tumor-Draining Lymph Nodes and T-Cell Priming
by: Dechen Wangmo, et al.
Published: (2021-10-01) -
Allogeneic tumor cell-derived extracellular vesicles stimulate CD8 T cell response in colorectal cancer
by: Travis J. Gates, et al.
Published: (2023-12-01) -
Acquired Resistance to Immune Checkpoint Blockade Therapies
by: Xianda Zhao, et al.
Published: (2020-05-01) -
Tumor-draining lymph nodes: opportunities, challenges, and future directions in colorectal cancer immunotherapy
by: Tingting Zhu, et al.
Published: (2024-01-01) -
Pharmacokinetics and pharmacodynamics of therapeutic antibodies in tumors and tumor-draining lymph nodes
by: Eric Salgado, et al.
Published: (2021-04-01)